Education
About Us
Working with TipRanks
Follow Us
HeartBeam (BEAT)
NASDAQ:BEAT
Earnings Data
Report Date
Mar 19, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.16Last Year’s EPS
-0.18Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress towards FDA clearance and commercial readiness, including strategic partnerships and successful clinical trials. However, the tight cash position and dependence on the FDA clearance present notable challenges.Company Guidance
FDA 510(k) Clearance Progress
HeartBeam continues to anticipate FDA clearance for their 12-Lead ECG synthesis software by the end of the year, building on their previous FDA clearance received in December 2024.
Partnership with HeartNexus
HeartBeam announced a partnership with HeartNexus to provide on-demand board-certified cardiologist reviews, enhancing the company's commercial readiness.
Successful Clinical Trials
The VALID-ECG pivotal study demonstrated a 93.4% overall diagnostic agreement between HeartBeam's synthesized 12-Lead ECG and a standard 12-Lead ECG for arrhythmia assessment.
Cash Management and Financial Discipline
HeartBeam achieved an 8% decrease in net cash used in operating activities quarter-over-quarter, building on a previous 23% decrease, reflecting strong financial discipline.
Expansion of Intellectual Property
HeartBeam added 3 newly issued patents, bringing the total to 24, and was recognized as a global IP leader in portable cardiac diagnostics.
BEAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BEAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $1.57 | $1.56 | -0.64% |
Aug 13, 2025 | $1.20 | $1.11 | -7.50% |
May 13, 2025 | $1.71 | $1.60 | -6.43% |
Mar 13, 2025 | $2.02 | $2.05 | +1.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does HeartBeam (BEAT) report earnings?
HeartBeam (BEAT) is schdueled to report earning on Mar 19, 2026, After Close (Confirmed).
What is HeartBeam (BEAT) earnings time?
HeartBeam (BEAT) earnings time is at Mar 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BEAT EPS forecast?
BEAT EPS forecast for the fiscal quarter 2025 (Q4) is -0.16.